SY-LB-57

SY-LB-57 is a highly potent bone morphogenetic protein ( BMP ) receptor signaling agonist. SY-LB-57 can be used in studies of diseases such as fractures and pulmonary arterial hypertension. In Vitro SY-LB-57 (0.01-1000 μM, 24 h) can significantly induce cell proliferation at concentrations below 10 µM with an IC 50 value of 807.93 µM in C2C12 cells. SY-LB-57 (0.01-10 μM, 15-30 min) increases the phosphorylation of Smad protein and promotes p-Smad nuclear translocation while activates the PI3K/Akt pathway and induces cytoplasmic localization of p-Akt. SY-LB-57 (0.01-10 μM, 24 h) can induce cell cycle shift towards proliferation. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Viability AssayCell Line: C2C12 cells Concentration: 0.01-1000 μM Incubation Time: 24 hours Result: Resulted in 85% reduction in the cell viability of C2C12 at 1 mM while increased cell viability by 280%, 290%, 200%, 150% and 50% at 0.01 µM, 0.1 µM, 1 µM, 10 µM and 100 µM, respectively. Western Blot AnalysisCell Line: C2C12 cells Concentration: 0.01-10 μM Incubation Time: 15min or 30 min Result: Significantly increased phosphorylation of Smad protein, 50% to 257% higher compared to control after 30 min. Showed a significant increase in p-Akt expression levels, exceeding the control by 667-1081% after 15 min. Cell Cycle AnalysisCell Line: C2C12 cells Concentration: 0.01-10 μM Incubation Time: 24 hours Result: Resulted in a significant decrease in the percentage of G0/G1 phase cells and a dramatic increase in S and G2/M phase cells. Form:Solid

No numbering system information yet

No physical and chemical property information yet

No safety information yet

No production method and use information yet

No upstream information yet

No downstream information yet

No related product information yet